GGrantIndex
← Leaderboards

Nicolas Schlecht

Icahn School Of Medicine At Mount Sinai

$8,465,862
Attributed
$21,963,714
Total exposure
9
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$21,963,714 · 9

By mechanism

R01$19,158,536 · 3
R21$1,385,131 · 3
R56$1,257,069 · 2
R03$162,978 · 1

Top collaborators

Most similar at Icahn School Of Medicine At Mount Sinai

Same institution · by research overlap

Others in their field

Top investigators on “Infection

Research focus

InfectionHuman PapillomavirusSamplingIncidenceDetectionProspectiveOralRisk FactorsHuman Papillomavirus 16High RiskHuman Papilloma Virus InfectionSpecimenDesignCohort StudiesLesionSmokingPrevalenceReportingParticipantFutureHpv-High RiskHuman Papilloma Virus VaccinationOral CavityCohort

Grant awards (34)

Cervical, Anal & Oral HPV Persistence/Adolescent Girls$1,215,107
R01 · FY2025 · AI
Impact of HIV, oral microbiome and mycobiome on oral HPV persistence$810,013
R01 · FY2025 · DE
Host and microbial risk factors of oral thrush in cancer patients receiving chemotherapy$726,289
R01 · FY2025 · DE
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$1,231,345
R01 · FY2024 · AI
Impact of HIV, oral microbiome and mycobiome on oral HPV persistence$801,143
R01 · FY2024 · DE
Host and microbial risk factors of oral thrush in cancer patients receiving chemotherapy$713,351
R01 · FY2024 · DE
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$1,256,429
R01 · FY2023 · AI
Impact of HIV, oral microbiome and mycobiome on oral HPV persistence$820,582
R01 · FY2023 · DE
Host and microbial risk factors of oral thrush in cancer patients receiving chemotherapy$770,829
R01 · FY2023 · DE
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$924,957
R01 · FY2022 · AI
Impact of HIV, oral microbiome and mycobiome on oral HPV persistence$858,030
R01 · FY2022 · DE
Host and microbial risk factors of oral thrush in cancer patients receiving chemotherapy$797,805
R01 · FY2022 · DE
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$921,365
R01 · FY2021 · AI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$917,545
R01 · FY2020 · AI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$914,592
R01 · FY2019 · AI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$927,425
R01 · FY2018 · AI
Impact of HIV, oral microbiome and mycobiome on oral HPV$422,533
R56 · FY2018 · DE · contact PI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$762,612
R01 · FY2017 · AI
Beta & Gamma Oral HPV infection in HIV positive individuals$133,869
R21 · FY2017 · DE · contact PI
Beta & Gamma Oral HPV infection in HIV positive individuals$74,881
R21 · FY2017 · DE · contact PI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$780,197
R01 · FY2016 · AI
Beta & Gamma Oral HPV infection in HIV positive individuals$250,500
R21 · FY2016 · DE · contact PI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$1,253,871
R01 · FY2015 · AI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$1,028,088
R01 · FY2014 · AI
Developing a HPV-mediated DNA methylation panel in HNSCC$118,639
R21 · FY2014 · DE · contact PI
Developing a HPV-mediated DNA methylation panel in HNSCC$90,111
R21 · FY2014 · DE · contact PI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$686,990
R01 · FY2013 · AI
Developing a HPV-mediated DNA methylation panel in HNSCC$250,500
R21 · FY2013 · DE · contact PI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$39,971
R01 · FY2013 · AI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$834,536
R56 · FY2012 · AI
Oral HPV and lesions in an HIV positive population$204,923
R21 · FY2012 · DE · contact PI
Oral HPV and lesions in an HIV positive population$261,708
R21 · FY2011 · DE · contact PI
HPV Induced Pathogenesis in Head and Neck Cancer$80,561
R03 · FY2006 · CA · contact PI
HPV Induced Pathogenesis in Head and Neck Cancer$82,417
R03 · FY2005 · CA